Europe Transient Protein Expression Market is expected to reach US$ 245.9 million by 2027

Instruments Segment Held Largest Share of Product Type in Europe Transient Protein Expression Market in 2019

According to a new market research study of ‘Europe Transient Protein Expression Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by product type, application, and end user’ the Europe Transient protein expression market is expected to reach US$ 245.9 million in 2027 from US$ 172.5 million in 2019. The market is estimated to grow with a CAGR of 4.7% from 2020-2027. The report provides trends prevailing in the Europe Transient protein expression market and the factors driving market along with those that act as hindrances.

Based on the product type, the transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instrument segment held the largest share of the market, whereas the expression vectors segment is expected to register the highest CAGR during the forecast period. A plasmid or virus engineered for gene expression in cells is typically an expression vector, otherwise known as an expression construct. The vector is used to insert a particular gene into a target cell and can command the protein synthesis process of the cell to generate the gene-encoded protein. Expression vectors are correlated with the actual mRNA and protein expression of the gene in the target organism. Virus based expression vectors have been widely used for gene therapy.

The growth of this market is estimated to grow owing to key driving factors such as the increasing applications of protein expression and the growing adoption of precision medicines. However, the market is expected experiencing slow growth during the forecast period owing to the high cost of products.

Thermo Fisher Scientific Inc., MERCK KGaA, QIAGEN, GenScript, Promega Corporation, Takara Bio Inc., MERIDIAN BIOSCIENCE, INC., New England Biolabs, Agilent Technologies, Inc., Mirus Bio LLC, Sino Biological Inc. are among the leading companies operating in the Europe Transient protein expression market. 

The report segments Europe Transient Protein Expression Market as Follows:

By Product Type

• Instruments
  • Automated Transient Protein Expression Systems
  • Manual Transient Protein Expression Systems
• Reagents
• Expression Vectors
• Competent Cells

By Application

• Genomic Research
• Gene Therapy
• Bio Production
• Cancer Research
• Drug Development

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Clinical Research Organizations

By Country

• Europe

• • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe